Division of Pathology and Laboratory Medicine, University of Texas M. D. Anderson Cancer Center, 8515 Fannin Street, Houston, TX 77054, USA.
Arch Pathol Lab Med. 2012 May;136(5):510-6. doi: 10.5858/arpa.2010-0638-OA.
Epidermal growth factor receptor (EGFR) is overexpressed in up to 80% of colorectal and endometrial carcinomas. Deletions of the polyA tract in the 3' untranslated region (3' UTR) have been reported in microsatellite instability-high (MSI-H) colonic carcinomas, but their impacts on EGFR expression and downstream pathways are unclear. This phenomenon has not been reported in other MSI-H tumors.
To assess the 3' UTR polyA tract of EGFR in both endometrial and colorectal carcinomas and the mutational status of EGFR downstream pathways.
Ninety-eight colorectal carcinomas and 47 endometrial carcinomas were included. EGFR 3' UTR polyA status was detected by capillary electrophoresis and Sanger sequencing. EGFR gene expression, EGFR copy numbers, and KRAS and BRAF mutation status were analyzed accordingly.
The 3' UTR polyA tract was deleted in 18 of 23 (78%) MSI-H versus 0 of 24 microsatellite-stable endometrial carcinomas (P < .001). Similar observations were seen in colorectal carcinomas, in which 29 of 36 (81%) MSI-H, 1 of 62 (1.6%) microsatellite instability-low, and none of the microsatellite-stable tumors harbored the deletion (P < .001). A moderate increase in EGFR mRNA level was observed in endometrial carcinomas with 3' UTR polyA deletions versus those with wild-type polyA tract. Amplification of the EGFR gene was not observed. Deletions in polyA tract do not seem to affect the frequency of KRAS and BRAF mutations.
Deletions of EGFR 3' UTR polyA are frequent in endometrial and colorectal carcinomas, are confined almost exclusively to MSI-H tumors, and do not affect KRAS and BRAF mutations.
表皮生长因子受体(EGFR)在高达 80%的结直肠癌和子宫内膜癌中过表达。已经在微卫星不稳定高(MSI-H)结肠癌细胞中报道了 3'非翻译区(3'UTR)的多聚 A 序列缺失,但它们对 EGFR 表达和下游途径的影响尚不清楚。这种现象尚未在其他 MSI-H 肿瘤中报道。
评估 EGFR 在子宫内膜癌和结直肠癌中的 3'UTR 多聚 A 序列和 EGFR 下游途径的突变状态。
纳入了 98 例结直肠癌和 47 例子宫内膜癌。通过毛细管电泳和 Sanger 测序检测 EGFR 3'UTR 多聚 A 状态。相应地分析 EGFR 基因表达、EGFR 拷贝数以及 KRAS 和 BRAF 突变状态。
在 23 例 MSI-H 子宫内膜癌中,有 18 例(78%)存在 3'UTR 多聚 A 序列缺失,而 24 例微卫星稳定型子宫内膜癌中无一例缺失(P <.001)。在结直肠癌中也观察到类似的结果,在 36 例 MSI-H 中,有 29 例(81%)、62 例微卫星不稳定性低中有 1 例(1.6%)和微卫星稳定型肿瘤中均未缺失(P <.001)。与野生型多聚 A 序列相比,子宫内膜癌中 3'UTR 多聚 A 缺失的 EGFR mRNA 水平有适度增加。未观察到 EGFR 基因扩增。多聚 A 序列缺失似乎不影响 KRAS 和 BRAF 突变的频率。
EGFR 3'UTR 多聚 A 缺失在子宫内膜癌和结直肠癌中很常见,几乎仅局限于 MSI-H 肿瘤,并且不影响 KRAS 和 BRAF 突变。